Glycopyrrolate Tablet
NDC Package 71921-111-01
Package Information
Glycopyrrolate tablets are indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer.Limitations of UseGlycopyrrolate tablets are not indicated as monotherapy for the treatment of peptic ulcer because effectiveness in peptic ulcer healing has not been established. This formulation utilizes a tablet delivery system. Marketed by Florida Pharmaceutical Products, Llc, this product is identified by NDC 71921-111 and is authorized under FDA application ANDA091182.
Identification & Billing
- RxCUI: 197738 - glycopyrrolate 1 MG Oral Tablet
- RxCUI: 197739 - glycopyrrolate 2 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71921 - Florida Pharmaceutical Products, Llc
- 71921-111 - Glycopyrrolate
- 71921-111-01 - 100 TABLET in 1 BOTTLE
- 71921-111 - Glycopyrrolate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71921-111-01 identifies a specific commercial package of 100 tablet in 1 bottle of Glycopyrrolate, a human prescription drug labeled by Florida Pharmaceutical Products, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains glycopyrrolate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Florida Pharmaceutical Products, Llc on February 12, 2026. The current certification is valid through December 31, 2027.
How is this Florida Pharmaceutical Products, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71921011101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.